Lexaria Bioscience Corp.
LEXX
Revenue
84.00k
▼-61.00k▼-42.07%
3 Months ChangeAssets
10.02M
▲3.67M▲57.72%
3 Months ChangeLiabilities
271.38k
▲67.17k▲32.89%
3 Months ChangeFree Cash Flow
-1.18M
▲84.16k▲6.65%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-18
Form 8-K
ID: 0001640334-24-001541
2024-10-16
Form 8-K
ID: 0001640334-24-001537
2024-10-02
Form 8-K
ID: 0001640334-24-001473
2024-09-05
Form 8-K
ID: 0001640334-24-001396
2024-08-22
Form 8-K
ID: 0001640334-24-001346
2024-07-17
Form 8-K
ID: 0001640334-24-001132
2024-07-12
Form 10-Q
ID: 0001640334-24-001091
2024-04-30
Form 8-K
ID: 0001640334-24-000708
2024-04-24
Form 8-K
ID: 0001640334-24-000702
2024-04-09
Form 10-Q
ID: 0001640334-24-000589